Skip to content
Review Open access

A Review on Emerging Trends in Biotechnology-Based Sensors

2022 · International Journal of Modern Innovations and Emerging Trends · 0 citations

TL;DR

Challenges remain in receptor stability, nanomaterial reproducibility, large-scale manufacturing, regulatory approval, AI transparency, and sustainable disposal of single-use sensors.

Abstract

Biosensors, or biotechnology-based sensors, have evolved from laboratory prototypes into key tools in healthcare diagnostics, food safety, environmental monitoring, industrial bioprocess control, and precision agriculture. They combine biological recognition elements—enzymes, antibodies, nucleic acids, aptamers, or cells—with transduction systems such as electrochemical, optical, piezoelectric, thermal, or magnetic mechanisms to detect biochemical interactions. Advances in nanotechnology, microfluidics, synthetic biology, wearable electronics, and data-driven analytics have improved biosensor performance by enabling lower detection limits, faster responses, multiplex detection, better function in complex samples, and support for point-of-care or at-home testing. Multiplex biosensors detect multiple biomarkers simultaneously using technologies like microarrays, barcoded nanoparticles, and multi-electrode arrays, which is valuable for diseases such as cancer and inflammatory disorders. Nanomaterials—including graphene, MoS₂, carbon nanotubes, metal-organic frameworks, plasmonic nanostructures, and engineered nanoparticles—enhance sensitivity by increasing surface area and improving signal transfer. Antifouling strategies such as PEGylation, zwitterionic coatings, and hydrogels maintain sensor performance in complex samples like blood, saliva, sweat, and wastewater. Wearable biosensors use flexible materials and epidermal electronics to continuously monitor analytes in sweat, tears, or interstitial fluid and connect wirelessly to smartphones through Bluetooth or NFC for real-time monitoring. Machine learning and AI improve data analysis, while CRISPR-based biosensors using Cas12 and Cas13 allow highly specific nucleic acid detection. Synthetic biology also enables programmable cell-based biosensors. In industrial biotechnology, biosensors monitor glucose, lactate, pH, dissolved oxygen, and product levels in real time to optimize process efficiency and yield. Environmental biosensors detect heavy metals, pesticides, endocrine-disrupting chemicals, and microbial contamination, often integrated with IoT networks. However, challenges remain in receptor stability, nanomaterial reproducibility, large-scale manufacturing, regulatory approval, AI transparency, and sustainable disposal of single-use sensors.

Read PDF

Similar papers

Review Aug 2026

Recent Advancements of Nano-Biosensors in Nanotheranostics: An Update

Nanotechnology has brought transformative advancements across numerous sectors, particularly in medicine. One of its most impactful applications lies in biomedical diagnostics, where the development of nanosensors has significantly enhanced the detec-tion and identification of disease-related biomarkers. These nano...

J. Dash, G. Pattnaik, Subhranshu Acharya et al. · 0 citations
Review Aug 2026

Next-Generation Nanosensors: Role of Advanced Nanomaterials, Artificial Intelligence, and Smart Sensing Systems

Nanomaterial based nanosensors have emerged as highly sensitive and selective analytical platforms for the rapid detection of physical, chemical, and biological analytes, offering significant advantages over conventional sensing technologies. The remarkable improvements in sensing performance have been made possible du...

Snigdha Siddh, Ashish Tiwari, Neetu Kumari et al. · 0 citations
Review Open access Aug 2026

Artificial Intelligence in Biosensor Systems for Healthcare: From Molecular Recognition to Machine Learning

By linking molecular-level recognition with computational signal interpretation, this review highlights the advantages and limitations of artificial intelligence-integrated biosensors for next-generation point-of-care diagnostics, continuous health monitoring, and personalized healthcare applications.

Ö. Altıntaş, Adil Denizli · 0 citations
Review Open access Jul 2026

Smart wearable biosensors: a transformative synergy between diagnosis and treatment of disease

This review provides a critical chemistry-to-clinical perspective on smart wearable biosensors and outlines the validation, manufacturing, cybersecurity, post-market surveillance and benchmarking requirements needed for their translation into reliable diagnostic and therapeutic-monitoring technologies.

Yachana Misha, Radheshyam Jena, Aman Shukla et al. · 0 citations
Review Open access Aug 2026

Nanomaterials-enabled point-of-care diagnostics for pathogens

The functional roles of representative nanomaterials in pathogen POCT, including optical signal output, catalytic signal amplification, target enrichment, and interfacial regulation are summarized, and their applications in respiratory, urinary, and fecal specimens are discussed.

Jiao Wu, Deng-Chao Wang, Wan-Ping Ye et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.